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Conclusions Biologically significant stages of precancer-
ous lesions were already detectable after 4 weeks of BBN 
exposure, considerably earlier than previously described in 
the literature.
Keywords Urothelium · Carcinogenesis · N-butyl-N-(4-
hydroxybutyl)nitrosamine · DNA cytophotometry
Background
The formal pathogenesis of experimentally induced uri-
nary bladder carcinoma has been differentially described 
in numerous publications. As in the present work, a 0.05 % 
N-butyl-N-(4-hydroxybutyl)nitrosamine solution as drink-
ing water in animal studies was frequently the carcinogen 
used (Akagi et al. 1973; Arai et al. 1974; Ito et al. 1975; 
Ito 1976; Kunze et al. 1976; Murphy and Irving 1981; 
Fukushima et al. 1982; Oliveira et al. 2005, 2007; Palmeira 
et al. 2009; Vasconcelos-Nobrega et al. 2012). Other 
researchers have used N-(4-(5-nitro-2-furyl)-2-thiazolyl)
formamide (Tiltman and Fridell 1971; Cohen et al. 1976), 
or N-methyl-N-nitrosourea (Hicks and Chowaniec 1978). 
Focal or multiple hyperplasias of the urothelium were fre-
quently observed first, while disturbances in stratification 
and maturation appeared in the hyperplasias after longer 
exposure periods (Ito 1976; Kunze et al. 1976; Murphy and 
Irving 1981; Fukushima et al. 1982; Oliveira et al. 2007; 
Tiltman and Fridell 1971; Hicks and Chowaniec 1978). 
These changes were designated as mild, moderate, or 
severe hyperplasia (Cohen et al. 1976), dysplasia, or car-
cinoma in situ (Oliveira et al. 2005, 2007). The spectrum 
of observed changes seemed to be identical with those of 
the human urinary bladder (Oliveira et al. 2007; Palmeira 
et al. 2009; Tiltman and Fridell 1971). Thus, we aimed to 
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Purpose The morphology of experimentally induced uri-
nary bladder precancerous lesions has been differentially 
interpreted in the literature. Here, we aimed to describe the 
development of precancerous lesions of the urothelium his-
tologically and by DNA cytophotometric analysis.
Methods We induced precancerous lesions of the urothe-
lium in 60 Wistar rats with 0.05 % N-butyl-N-(4-hydroxy-
butyl)nitrosamine (BBN) solution as drinking water. After 
exposure for 2–20 weeks, each animal received tap water 
for 2 weeks. Subsequently, six animals were killed every 
2 weeks, and urothelia of three urinary bladders per time 
point were examined by DNA cytophotometry of smear 
preparations. An additional three urinary bladders were 
processed for histological analysis.
Results Over 20 weeks, BBN exposure led to a signifi-
cant difference between the control group and most of the 
BBN-exposed 2-week groups and to differences between 
most of these time point groups. After week 4, this differ-
ence included a higher proportion of cells with increased 
nuclear DNA content. At the end of the experiment, DNA 
cytophotometric values of the urothelium in experimental 
rats corresponded to those of poorly differentiated urothe-
lial carcinomas.
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characterize the time-dependent morphological changes 
that occur during urothelium precancerous lesion develop-
ment in rats using both histological and DNA cytophoto-
metric analysis.
Materials and methods
Precancerous lesions were induced in urinary bladder 
urothelium of 60 female Wistar rats (Landeszuchtanstalt 
Hannover, Germany) by adding 0.05 ml BBN (Profes-
sor Dr. R. Preussmann, German Cancer Research Center, 
Heidelberg, Germany) to 100 ml of their drinking water. 
Three animals were held in each Makrolon cage (Ehret, 
Emmendingen, Germany). At the beginning of the experi-
ment, all rats weighed 180–200 g. Standard feed (Eggers-
mann, Rinteln, Germany) and BBN solution were provided 
ad libitum. Room temperature was 22 °C, relative humidity 
was 55 %, and the light–dark cycle was 12 h. Seven con-
trol animals received tap water. Experimental rats were 
treated with BBN for 2–20 weeks, followed by 2 weeks of 
tap water provision. Every 2 weeks, six animals were killed 
under ether anesthesia with a Nembutal overdose applied 
intraperitoneally (Abbott, Ludwigshafen, Germany). 
Urothelial smears of three urinary bladders at each time 
point were prepared and fixed in a methanol–formalin–ace-
tic acid solution (Böhm 1968). The optimal hydrolysis time 
of Feulgen staining (Pearse 1968) was 45 min at 28 °C in 
4 N HCl (Böhm 1968).
After staining with Schiff’s reagent (Graumann 1953), 
we covered the slides with coverslips using oil as inter-
medium (Cargille Laboratories, Cedar Grove, USA) and 
obtained measurements at 40-fold magnification on an 
M85a scanning microdensitometer (Vickers Instruments, 
York, UK) interfaced with an HP 9825A computer (Hewl-
ett-Packard, Böblingen, Germany). We used the recom-
mended wavelength of 570 nm for all measurements (Fossa 
1975). For the smears of each urinary bladder, we meas-
ured 100 cell nuclei by random placement (series A and 
B) or focused on the 50 largest nuclei of one selected area 
(series C). Lymphocytes from the same smear served as a 
reference for diploid DNA values. Measured values were 
divided into 24 classes with a breadth of 0.5c (0.25c to 
>11.75c) and analyzed using the Chi-square test.
For comparative histological examination, three animals 
per time point were perfusion-fixed with buffered forma-
lin–glutaraldehyde mixture (McDowell and Trump 1976). 
Semi-thin sections (Autocut 1140, Reichert-Jung, Wetzlar, 
Germany) of urinary bladder cross sections embedded in 
Technovit 7200 VLC (Haereus Kulzer, Wehrheim, Ger-
many) were stained with hematoxylin–eosin (HE).
Results
Histology
The urothelium of control animals was composed of one 
layer each of superficial, intermediate, and basal cells 
(Fig. 1). After 2 weeks of BBN treatment, the urothelium of 
experimental animals was slightly expanded and displayed 
increased numbers of basal and intermediate cells (Fig. 2). 
By week 4 of exposure, the intermediate cells had increased 
to five layers, their cylindrical nuclei oriented perpendicu-
lar to the basement membrane. Enlargement of individual 
nuclei aroused suspicion of a mild dysplasia (Fig. 3). At 
week 6, maturation of superficial cells was almost entirely 
absent. The urothelium was primarily composed of cell lay-
ers of varying thickness and appeared dysplastic as most 
nuclei were mildly to moderately enlarged. We noted mild-
to-moderate dysplasia in papillary urothelial proliferations 
and cornified squamous metaplasia at week 8. The dyspla-
sia foci had more strongly expanded by week 10.
Fig. 1  Normal three-layer urothelium (HE, ×400 magnification)
Fig. 2  Week 2: hyperplastic urothelium (HE, ×400 magnification)
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At week 12, mild-to-moderate dysplasia predominated 
the urinary bladders, followed by the appearance of small-
focus moderate atypias in urothelium, squamous metapla-
sia, and papillomatous tumors at week 14. At week 16, a 
moderate diffuse dysplasia of the urothelium and papillary 
tumors prevailed (Fig. 4). We observed severe nuclear ana-
plasia from weeks 18 to 20 (Fig. 5) and could not distin-
guish the complex proliferations of epithelia and stroma in 
the inverted papillary tumors from an invasive carcinoma 
by the conclusion of the experiment. 
DNA cytophotometry
Throughout the 20-week trial, DNA cytophotometric meas-
urements of cells from most of the experimental rats were 
significantly different from those in the control group. In 
addition, measurements of most of the 2-week experimen-
tal group significantly differed from each other (p < 0.05).
Resulting measurements and adapted comparative val-
ues of the random samples (A and B) are summarized in 
Table 1 and Fig. 6, while those of the selective sample 
(C) are summarized in Table 2 and Fig. 7. At week 2, we 
observed decreased values at 2.5c and 4.5c in favor of 
values at 1.5c and 2c and a peak at 3c. At week 4, values 
at 2.5c increased again, and atypical values appeared at 
7c and 9c. Tetraploid values had also increased and were 
broadly dispersed by week 6, as well as the appearance of 
DNA values in the octoploid region with higher frequency. 
Week 8 yielded atypical values at 7c and 10c and peaks at 
3c and 5c. Values at 5c and 7c had increased at week 10. 
From weeks 10 to 20, numerous additional values appeared 
at 3c, 6c, and 8c, and by week 20, 9 of 150 nuclei exhibited 
values in the >11.75c class.   
Discussion
Exposure to BBN induces selective tumor formation in 
urinary bladder urothelia in numerous species (Druck-
rey et al. 1964), including our chosen test model, which 
has been comprehensively reviewed previously (Vas-
concelos-Nobrega et al. 2012). To better characterize 
these BBN-induced precancerous changes, we analyzed 
DNA values of the epithelial cell nuclei cytophoto-
metrically in parallel with histological observations and 
noted many significant time-dependent developmental 
features.
Normal urothelium was comprised of three cell layers 
with primarily diploid DNA values (2c). After 2 weeks of 
BBN exposure, we observed mild urothelial hyperpla-
sia but without significant changes of the DNA values. At 
week 4, nuclei of intermediate cells became enlarged, and 
hyperdiploid DNA values increased. At week 6, histologi-
cal changes consistent with dysplasia were accompanied by 
increased tetraploid and octoploid DNA values. Foci with 
a slight to moderate and, finally, great nuclear enlargement 
were found during the following weeks, with increasing 
numbers and to an increasing degree. We noted varying 
amounts of atypical tri-, hexa-, and octoploid DNA val-
ues between weeks 10 and 20, and by week 20, papillary 
tumors and severe nuclear anaplasia of the urothelium were 
Fig. 3  Week 4: increased numbers and nuclear enlargement of inter-
mediate cells (HE, ×400 magnification)
Fig. 4  Week 16: moderate-to-severe dysplasia of the urothelium 
(HE, ×400 magnification)
Fig. 5  Week 18: papillary tumor with atypical urothelium (HE, ×40 
magnification)
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present, together with numerous nuclear DNA values in the 
>11.75c class.
The morphology of experimentally induced precancerous 
lesions of the urinary bladder has been interpreted differently 
throughout the literature due to a lack of a consistent classifica-
tion system. In addition, detailed cytological analyses are lim-
ited (Murphy and Irving 1981). Common histological changes 
observed after BBN exposure include polyploid, papillary, or 
solid focal hyperplasias after 8 weeks (Ito 1976); hyperplasias, 
papillomas, and carcinoma appearance after 12 weeks BBN 
followed by 28 weeks tap water (Ito et al. 1975) and 20 weeks 
BBN (Akagi et al. 1973); and focal hyperplasias with few 
atypias that were interpreted as precancerous lesions as well 
as formation of papillary transitional cell carcinomas after 
20 weeks of BBN exposure (Arai et al. 1974). Large numbers 
of papillary hyperplasias and papillomas with few atypias or 
in situ carcinomas, and individual invasive tumors have all 
been observed after 12 weeks BBN followed by 21 weeks tap 
water (Kunze et al. 1976). Many hyperplasias demonstrated 
considerable nuclear polymorphism (Hicks and Chowaniec 
1978).
Only recently DNA cytophotometric examinations of 
experimentally induced urinary bladder tumors have been 
described (Oliveira et al. 2005, 2007; Palmeira et al. 2009). 
For example, after 4 weeks of BBN exposure, hyperplasias 
with 22.2 % aneuploid nuclei and dysplasias with 55.5 % 
aneuploid nuclei were found in paraffin sections from mice 
(Oliveira et al. 2005).
The general level of aneuploidy can, like the degree of 
proliferation, be determined by flow cytometry at relatively 
low cost (Gustafson and Tribukait 1985) but with a mini-
mum of 10,000 cells per probe (Tribukait et al. 1979). One 
limitation of this approach is that it only separates low-
grade from high-grade bladder tumors that are designated 
as diploid or aneuploid (Tribukait et al. 1982).
DNA image cytometry has the advantage of a higher 
sensitivity over flow cytometry on cell populations with 
small aneuploid peaks (Palmeira et al. 2008).
This high resolution could be maintained even with 
grade 1 urothelial carcinomas by improving the precision 
of measurements and the introduction of sensitive statisti-
cal tests to identify DNA-aneuploid stemlines. This DNA-
aneuploid stemline interpretation system yielded a sensi-
tivity of 76.3 % and a specificity of 100 % when applied 
to biopsy specimens of 60 grade 1 urothelial carcinomas 
and 50 biopsy specimens of normal bladder mucosa (Planz 
et al. 1996).
Like the interpretation of histological findings, that of 
nuclear DNA values of experimental bladder tumors is also 
not standardized. The normal urinary bladder epithelium 
Table 1  DNA values, series A 
and B
Class C W0 W2 W4 W6 W8 W10 W12 W14 W16 W18 W20
1 0.25–0.75
2 0.75–1.25
3 1.25–1.75 13 22 2 3 1
4 1.75–2.25 1036 522 359 344 191 40 76 175 234 199 168
5 2.25–2.75 247 11 179 198 354 422 309 262 240 261 310
6 2.75–3.25 1 5 68 143 116 60 2 14
7 3.25–3.75 19 10 12 2 2 1 5 6 6 12 8
8 3.75–4.25 51 32 25 32 14 8 14 13 20 52 44
9 4.25–4.75 31 2 15 24 24 28 18 7 13 62 24
10 4.75–5.25 3 5 6 22 15 12 11 2 20
11 5.25–5.75 9 13 7 4 1 4
12 5.75–6.25 2 3 1 1
13 6.25–6.75 1 2 1
14 6.75–7.25 1 2 3
15 7.25–7.75 2
16 7.75–8.25
17 8.25–8.75 1 1
18 8.75–9.25 1 1 2 6 2
19 9.25–9.75 1




24 >11.75 2 2 2
1257J Cancer Res Clin Oncol (2016) 142:1253–1260 
1 3
of the rat is polyploid and comprised of diploid cells (2n) 
with 42 chromosomes (Oliveira et al. 2007), tetraploid (4n) 
cells, and a few octoploid (8n) cells (Cooper et al. 1969). 
The nuclear DNA content during cell cycle phase G1 is 
given a euploid or diploid DNA value (2c). Throughout 
S phase, the diploid DNA content doubles and may range 
from 2c to 4c (Kiefer and Sandritter 1976). In the normal 
urothelium, 1.7 % of cells are in S phase, while nearly 
20 % of cells of poorly differentiated carcinomas are in S 
phase (Farsund et al. 1984). In laboratory animals, tetra-
ploid cells can likewise divide after appropriate cellular 
damage (Cooper et al. 1969). Although the DNA content 
of individual cells in normal tissue may deviate from aver-
age values, it is typically stable. Dispersed or elevated 
DNA values indicate regeneration or a malignant process 
(Leuchtenberger et al. 1954), so DNA cytophotometric 
analysis cannot consistently distinguish between neoplasia 
and cellular regeneration (Murphy et al. 1986). The DNA 
content of well-differentiated urothelial tumors is similar 
to that of normal diploid cells (Fossa 1975), while cells of 
moderately and poorly differentiated bladder carcinomas 
are usually aneuploid (Gustafson and Tribukait 1985). Our 
unpublished measurements yielded average values of 2.4c 
for G1 transitional cell carcinomas (n = 34), 3.9c for G2 
tumors (n = 34), and 6.6c for G3 tumors (n = 22).
Representative (Table 1; Fig. 6) and selective (Table 2; 
Fig. 7) surveys of random samples in our current study 
revealed remarkably different findings. For example, only 
few pathological DNA values >6c (class 12) of series C 
were represented in series A and B.
Increased DNA values between 2c (class 4) and 4c (class 
8) at week 4 could be attributed to an elevated number of 
S-phase cells. However, at this time point increase in val-
ues at 4.5c to 5c and the occurrence of values at 7c and 9c 
were noteworthy. In addition, from week 4 on a relatively 
high peak at 2.5c had developed and remained till week 20, 
Fig. 6  Histogram, series A 
and B
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possibly representing a near-diploid cell line of low-grade 
dysplasia. The relative increase in values in the tetraploid 
range (4c, class 8) was striking at week 6, as these DNA 
values corresponded to those of a G2 carcinoma or moder-
ate dysplasia. Values between 4c and 8c at week 8, together 
with values beyond 11.75c, and peaks at 3c (class 6) at 
week 10 also suggested a neoplastic process. From week 
10 on, DNA values in peaks or a broad unimodal distribu-
tion corresponded to those of G3 carcinomas.
Histologically, we observed epithelial hyperplasia with 
slightly increased numbers of basal and intermediate cells 
at week 2. By week 4, however, the uniformity of cells 
and isolated atypical nuclei already indicated an early 
intraepithelial neoplasia or mild dysplasia. The increased 
near-diploid and tetraploid DNA values at week 4 pro-
vided no clarification (Murphy et al. 1986), particularly as 
we could not directly correlate DNA content with cellular 
morphology. However, our determination of mild dysplasia 
was supported by the occurrence of atypical values at 7c 
and 9c as well as by the results of Oliveira et al. (2005). 
At week 6 and afterwards, morphological characteristics 
and DNA values were evidence to suggest the develop-
ment of intraepithelial neoplasias that temporally increased 
in severity. Our findings indicated that, in an increasing 
number of cells, specific changes in nuclear DNA content 
occurred at random after appropriate exposure to BBN.
The test model presented here has been used recently in 
genetic and molecular pathological studies, leading to the 
characterization of p53 and H-Ras mutations, elevated val-
ues of epidermal growth factor receptor, loss of alleles, and 
chromosomal alterations during early, non-invasive stages 
of precancerous lesion development (Vasconcelos-Nobrega 
et al. 2012). Thus, future analyses of multiple genetic alter-
ations of the bladder urothelium now may be performed on 
a valid morphological basis.
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